QQ客服 官方微博 反馈留言

	Evaluation of the tumor targeting of a FAP alpha-based doxorubicin prodrug
	Huang, Sichao[1]; Fang, Rui[2]; Xu, Jun[1]; Qiu, Shenghong[1]; Zhang, Huan[1]; Du, Jun[2]; Cai, Shaohui[1]
	2011
卷号	19期号:[db:dc_citation_issue]页码:487
DOI	[db:dc_identifier_doi]
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3330090
专题	暨南大学
作者单位	1.[1]Jinan Univ, Coll Pharm, Dept Clin Pharmacol, Guangzhou 510632, Guangdong, Peoples R China 2.[2]Sun Yat Sen Univ, Sch Pharmaceut Sci, Ctr Microbiol Biochem & Pharmacol, Guangzhou 510006, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Huang, Sichao[1],Fang, Rui[2],Xu, Jun[1],et al. Evaluation of the tumor targeting of a FAP alpha-based doxorubicin prodrug[J],2011,19([db:dc_citation_issue]):487.
APA	Huang, Sichao[1].,Fang, Rui[2].,Xu, Jun[1].,Qiu, Shenghong[1].,Zhang, Huan[1].,...&Cai, Shaohui[1].(2011).Evaluation of the tumor targeting of a FAP alpha-based doxorubicin prodrug.,19([db:dc_citation_issue]),487.
MLA	Huang, Sichao[1],et al."Evaluation of the tumor targeting of a FAP alpha-based doxorubicin prodrug".19.[db:dc_citation_issue](2011):487.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。